BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2163816)

  • 1. Transposition of the abl proto-oncogene in Philadelphia--negative chronic myeloid leukaemia and acute lymphocytic leukaemia.
    Stopera SA; Davie JR; Ray M
    Cytobios; 1990; 61(246-247):161-70. PubMed ID: 2163816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific point mutations that activate v-abl are not found in Philadelphia-negative chronic myeloid leukaemia, Philadelphia-negative acute lymphoblastic leukaemia or blast transformation of chronic myeloid leukaemia.
    Melo JV; Goldman JM
    Leukemia; 1992 Aug; 6(8):786-90. PubMed ID: 1353550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The usefulness of the bcr/abl rearrangement in the diagnosis and evolution of chronic myeloid leukemia].
    González FA; Villegas A; Ferro MT; San Román C; Sáez I; López M; del Potro E; Alvarez A; Martínez R; Díaz Madiavilla J
    Med Clin (Barc); 1993 Oct; 101(14):521-4. PubMed ID: 8231395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further evidence of the involvement of the c-abl oncogene in chronic myelogenous leukemia and acute lymphocytic leukemia.
    Szabo P; Macera MJ; Verma RS
    Mol Biol Med; 1988 Dec; 5(3):139-44. PubMed ID: 3072467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusion of the bcr and the c-abl genes in Ph'-positive acute lymphocytic leukemia with no rearrangement in the breakpoint cluster region.
    ar-Rushdi A; Negrini M; Kurzrock R; Huebner K; Croce CM
    Oncogene; 1988 Apr; 2(4):353-7. PubMed ID: 3283653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interstitial insertion of varying amounts of ABL-containing genetic material into chromosome 22 in Ph-negative CML.
    Rassool F; Martiat P; Taj A; Klisak I; Goldman J
    Leukemia; 1990 Apr; 4(4):273-7. PubMed ID: 2164119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCR/ABL rearrangement in two cases of Philadelphia chromosome negative chronic myeloid leukemia: deletion on the derivative chromosome 9 may or not be present.
    Batista DA; Hawkins A; Murphy KM; Griffin CA
    Cancer Genet Cytogenet; 2005 Dec; 163(2):164-7. PubMed ID: 16337861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute lymphoid leukemia molecular phenotype in a patient with benign-phase chronic myelogenous leukemia.
    Guo JQ; Hirsch-Ginsberg CF; Xian YM; Stass SA; Champlin RE; Giralt SA; McCredie KB; Campbell ML; Arlinghaus RB
    Hematol Pathol; 1993; 7(2):91-106. PubMed ID: 8340287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic diversity correlates with clinical variation in Ph'-negative chronic myeloid leukaemia.
    Morris CM; Reeve AE; Fitzgerald PH; Hollings PE; Beard ME; Heaton DC
    Nature; 1986 Mar 20-26; 320(6059):281-3. PubMed ID: 3007992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The bcr gene is joined to c-abl in Ph1 chromosome negative chronic myelogenous leukemia.
    Dreazen O; Klisak I; Rassool F; Goldman JM; Sparkes RS; Gale RP
    Oncogene Res; 1988; 2(2):167-75. PubMed ID: 3217110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Ph-negative chronic myeloid leukemia with a complex BCR/ABL rearrangement and a t(6;9)(p21;q34.1).
    Todorić-Zivanović B; Marisavljević D; Surace C; Cemerikić V; Marković O; Krtolica K; Tatomirović Z; Cikota B; Magić Z; Rocchi M
    Cancer Genet Cytogenet; 2006 Apr; 166(2):180-5. PubMed ID: 16631477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Philadelphia translocation in CML and ALL: recent investigations, new detection methods.
    Hagemeijer A; van der Plas DC; Soekarman D; van Denderen J; Grosveld G
    Nouv Rev Fr Hematol (1978); 1990; 32(1):83-6. PubMed ID: 2190182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic myelogenous leukemia with typical clinical and morphological features can be Philadelphia chromosome negative and "bcr negative".
    Selleri L; Emilia G; Luppi M; Temperani P; Zucchini P; Tagliafico E; Artusi T; Sarti M; Donelli A; Castoldi GL
    Hematol Pathol; 1990; 4(2):67-77. PubMed ID: 2197265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia.
    Onida F; Ball G; Kantarjian HM; Smith TL; Glassman A; Albitar M; Scappini B; Rios MB; Keating MJ; Beran M
    Cancer; 2002 Oct; 95(8):1673-84. PubMed ID: 12365015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute leukaemia in bcr/abl transgenic mice.
    Heisterkamp N; Jenster G; ten Hoeve J; Zovich D; Pattengale PK; Groffen J
    Nature; 1990 Mar; 344(6263):251-3. PubMed ID: 2179728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Masked Philadelphia chromosome due to atypical BCR/ABL localization on the 9q34 band and duplication of the der(9) in a case of chronic myelogenous leukemia.
    Fugazza G; Garuti A; Marchelli S; Miglino M; Bruzzone R; Gatti AM; Castello S; Sessarego M
    Cancer Genet Cytogenet; 2005 Dec; 163(2):173-5. PubMed ID: 16337863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-expression of c-abl and c-myb oncogenes in Philadelphia chromosome-negative, bcr-negative chronic myeloid leukaemia.
    Tóth FD; Kiss J; Kiss A; Telek B; Oláh E; Iványi J; Rak K
    Leuk Res; 1994 May; 18(5):373-80. PubMed ID: 8182928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Atypical chronic myeloid leukemia with polymorphism of the BCR gene].
    Hernández A; Corral L; Muñiz A; Aláez C; Martínez G
    Sangre (Barc); 1991 Dec; 36(6):497-9. PubMed ID: 1687492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translocation of c-abl oncogene and PDGFB (c-sis) gene in a case of CML with 46,XY, t(22;22).
    Gradl G; Tesch H; Schwieder G; Wagner T; Fonatsch C
    Blut; 1989 Jun; 58(6):279-85. PubMed ID: 2660925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The BCR/ABL hybrid gene.
    Groffen J; Heisterkamp N
    Baillieres Clin Haematol; 1987 Dec; 1(4):983-99. PubMed ID: 3332859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.